232 related articles for article (PubMed ID: 33040614)
1. Comparative acute intravenous toxicity study of triple polymer-layered magnetic nanoparticles with bare magnetic nanoparticles in Swiss albino mice.
Ahmad A; Ansari MM; Kumar A; Vyawahare A; Mishra RK; Jayamurugan G; Raza SS; Khan R
Nanotoxicology; 2020 Dec; 14(10):1362-1380. PubMed ID: 33040614
[TBL] [Abstract][Full Text] [Related]
2. Dose dependent safety implications and acute intravenous toxicity of aminocellulose-grafted-polycaprolactone coated gelatin nanoparticles in mice.
Ahmad A; Ansari MM; AlAsmari AF; Ali N; Maqbool MT; Raza SS; Khan R
Int J Biol Macromol; 2021 Dec; 192():1150-1159. PubMed ID: 34653441
[TBL] [Abstract][Full Text] [Related]
3. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
Mohammed L; Ragab D; Gomaa H
Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
[TBL] [Abstract][Full Text] [Related]
4. Magnetic nanoparticles for drug targeting: from design to insights into systemic toxicity. Preclinical evaluation of hematological, vascular and neurobehavioral toxicology.
Agotegaray MA; Campelo AE; Zysler RD; Gumilar F; Bras C; Gandini A; Minetti A; Massheimer VL; Lassalle VL
Biomater Sci; 2017 Mar; 5(4):772-783. PubMed ID: 28256646
[TBL] [Abstract][Full Text] [Related]
5. Surface functionalized magnetic nanoparticles shift cell behavior with on/off magnetic fields.
Jeon S; Subbiah R; Bonaedy T; Van S; Park K; Yun K
J Cell Physiol; 2018 Feb; 233(2):1168-1178. PubMed ID: 28464242
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and acute toxicity of a nanofluid containing manganese iron oxide nanoparticles produced by a mechanochemical process.
Bellusci M; La Barbera A; Padella F; Mancuso M; Pasquo A; Grollino MG; Leter G; Nardi E; Cremisini C; Giardullo P; Pacchierotti F
Int J Nanomedicine; 2014; 9():1919-29. PubMed ID: 24790434
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of L-DOPA coated iron oxide nanoparticles in intraperitoneal delivery setting - preliminary preclinical study.
Comănescu MV; Mocanu MA; Anghelache L; Marinescu B; Dumitrache F; Bădoi AD; Manda G
Rom J Morphol Embryol; 2015; 56(2 Suppl):691-6. PubMed ID: 26429160
[TBL] [Abstract][Full Text] [Related]
8. The interaction of polymer-coated magnetic nanoparticles with seawater.
Kadar E; Batalha IL; Fisher A; Roque AC
Sci Total Environ; 2014 Jul; 487():771-7. PubMed ID: 24315028
[TBL] [Abstract][Full Text] [Related]
9. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
[TBL] [Abstract][Full Text] [Related]
10. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
11. Applications of Magnetic Nanoparticles in Targeted Drug Delivery System.
Mou X; Ali Z; Li S; He N
J Nanosci Nanotechnol; 2015 Jan; 15(1):54-62. PubMed ID: 26328305
[TBL] [Abstract][Full Text] [Related]
12. Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.
Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S; Shahzad S
Appl Biochem Biotechnol; 2014 May; 173(1):36-54. PubMed ID: 24615524
[TBL] [Abstract][Full Text] [Related]
13. Thermal and magnetic properties of chitosan-iron oxide nanoparticles.
Soares PI; Machado D; Laia C; Pereira LC; Coutinho JT; Ferreira IM; Novo CM; Borges JP
Carbohydr Polym; 2016 Sep; 149():382-90. PubMed ID: 27261762
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo acute toxicity of a novel citrate-coated magnetite nanoparticle.
Rocha JMV; de Souza VB; Panunto PC; Nicolosi JS; da Silva EDN; Cadore S; Londono OM; Muraca D; Tancredi P; de Brot M; Nadruz W; Ruiz ALTG; Knobel M; Schenka AA
PLoS One; 2022; 17(11):e0277396. PubMed ID: 36395271
[TBL] [Abstract][Full Text] [Related]
15. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
16. In vivo MRI assessment of bioactive magnetic iron oxide/human serum albumin nanoparticle delivery into the posterior segment of the eye in a rat model of retinal degeneration.
Tzameret A; Ketter-Katz H; Edelshtain V; Sher I; Corem-Salkmon E; Levy I; Last D; Guez D; Mardor Y; Margel S; Rotenstrich Y
J Nanobiotechnology; 2019 Jan; 17(1):3. PubMed ID: 30630490
[TBL] [Abstract][Full Text] [Related]
17. Influence of chitosan coating on magnetic nanoparticles in endothelial cells and acute tissue biodistribution.
Agotegaray M; Campelo A; Zysler R; Gumilar F; Bras C; Minetti A; Massheimer V; Lassalle V
J Biomater Sci Polym Ed; 2016 Aug; 27(11):1069-85. PubMed ID: 27251857
[TBL] [Abstract][Full Text] [Related]
18. Amorphous silica coatings on magnetic nanoparticles enhance stability and reduce toxicity to in vitro BEAS-2B cells.
Baber O; Jang M; Barber D; Powers K
Inhal Toxicol; 2011 Aug; 23(9):532-43. PubMed ID: 21819260
[TBL] [Abstract][Full Text] [Related]
19. Phenyl alanine & Tyrosine Amino acids Coated Magnetic Nanoparticles: Preparation and Toxicity study.
Nosrati H; Hamzehei H; Afroogh S; Ashabi SF; Attari E; Manjili HK
Drug Res (Stuttg); 2019 May; 69(5):277-283. PubMed ID: 30189461
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of polyacrylic acid-coated iron oxide nanoparticles is associated with proinflammatory activation and liver toxicity.
Couto D; Freitas M; Costa VM; Chisté RC; Almeida A; Lopez-Quintela MA; Rivas J; Freitas P; Silva P; Carvalho F; Fernandes E
J Appl Toxicol; 2016 Oct; 36(10):1321-31. PubMed ID: 27102234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
